Phase I/II dose-finding study of nanoparticle albumin-bound paclitaxel (nab®-Paclitaxel) plus Cisplatin as Treatment for Metastatic Nasopharyngeal Carcinoma

    BMC cancer, Volume 16, Issue 1, 2016, Pages 464

    Cited by: 0|Bibtex|Views2|Links
    WOS
    Keywords:
    Paclitaxel Maximum Tolerate Dose Dose Cohort Granulocyte Colony Stimulate Factor Treatment Metastatic Nasopharyngeal Carcinoma

    Abstract:

    ClinicalTrials.gov ID: NCT01735409 . The trial was registered on November 20th, 2012.

    Code:

    Data:

    Your rating :
    0

     

    Tags
    Comments